Every finding on record at Bayada Home Health Care, Inc.

It is required that the documented comprehensive assessment includes a drug profile that contains the patient's current prescription and over-the-counter (OTC) drugs; supplements; herbal remedies; [and] other alternative treatments that could affect drug therapy. The medication review process includes the identification of the effectiveness of drug therapy; drug side effects;actual or potential drug interactions; duplicate drug therapy; and drug therapy associated with laboratory monitoring. The assessment includes evidence that common side effects of medication in the hospice populations are anticipated, and, as appropriate, preventive measurements are implemented to manage the side effects. The drug profile is updated per the hospice policy and procedure, but, at minimum, at the time of each comprehensive assessment and/or when new medication is added or changes are made to existing medication. This standard was not met as evidenced by clinical record review and interview. In 1 of 14 (7%) clinical records reviewed, the agency did not ensure that the patient's drug profile contained the patient's current prescriptions. Clinical Record 9: The patient was admitted to hospice services on 2/27/2023 with a diagnosis of heart disease. The Registered Nurse visit note dated 3/14/23 documented that the patient was on oxygen 5 liters via nasal cannula. Oxygen supplies were documented in the supplies section of the plan of care. Oxygen was not documented in the patient's medication profile. During a joint clinical record review and interview, the Clinical Director confirmed that oxygen was not added to the patient's medication profile.